Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 190 citing articles:

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 59
Exploring the emerging trends in the synthesis and theranostic paradigms of cerium oxide nanoparticles (CeONPs): A comprehensive review
Sagnik Nag, Oishi Mitra, P. Sankarganesh, et al.
Materials Today Chemistry (2024) Vol. 35, pp. 101894-101894
Closed Access | Times Cited: 29
Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 17
The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health
Prakasini Satapathy, Pawan Kumar, Jeetendra Kumar Gupta, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 4, pp. 2498-2501
Open Access | Times Cited: 13
Genetic Conservation and Diversity of SARS‐CoV‐2 Envelope Gene Across Variants of Concern
Baoming Liu, Qiaobin Yao, Ruth Cruz‐Cosme, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Closed Access | Times Cited: 2
The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting
Ching‐Wen Hou, Stacy Williams, Guillermo Trivino-Soto, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 1, pp. e0003893-e0003893
Open Access | Times Cited: 1
Tracing Emergence of SARS-CoV-2 Variants: Insights from Comprehensive Assessment Using Reverse Transcription Polymerase Chain Reaction and Whole Genome Sequencing
D. Na, Yuna Hong, C. Lee, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 311-311
Open Access | Times Cited: 1
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 263-266
Open Access | Times Cited: 25
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 21
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters
Rana Abdelnabi, Ria Lassaunière, Piet Maes, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 122-122
Open Access | Times Cited: 8
A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Vaccine (2024) Vol. 42, Iss. 15, pp. 3389-3396
Open Access | Times Cited: 8
EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19
Abdolreza Esmaeilzadeh, Fereshteh Ebrahimi, Armin Jahani Maleki, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 337-343
Closed Access | Times Cited: 7
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization
Tania Ciaglia, Vincenzo Vestuto, Veronica Di Sarno, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116128-116128
Open Access | Times Cited: 7
Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II
Cheng‐Han Lin, Ho-Ju Chang, M. C. Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2935-2935
Open Access | Times Cited: 7
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant
Robert Flisiak, Dorota Zarębska‐Michaluk, Krystyna Dobrowolska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5572-5572
Open Access | Times Cited: 17
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
Jennifer Serwanga, Violet Ankunda, Jackson Sembera, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study
Maria C. Magnus, Jonas Söderling, Anne K. Örtqvist, et al.
BMJ (2024), pp. e079364-e079364
Closed Access | Times Cited: 6
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Nungruthai Suntronwong, Sitthichai Kanokudom, Thaneeya Duangchinda, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chronic Hepatitis B and COVID-19 Clinical Outcomes in the United States: A Multisite Retrospective Cohort Study
George A. Yendewa, Temitope Olasehinde, Frank Mulindwa, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 2
Open Access
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Zhe Chen, Leilei Feng, Lei Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
Inga Tometten, Tobias Brandt, Maike Schlotz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Analysis of longitudinal social media for monitoring symptoms during a pandemic
Shixu Lin, Lucas Garay, Yining Hua, et al.
Journal of Biomedical Informatics (2025), pp. 104778-104778
Closed Access
Page 1 - Next Page

Scroll to top